Position in NUVB
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$5,894,231
+$380,230 QoQ
Shares Held
1,373,947
+123.3% QoQ
Ownership
0.395%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NUVB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,307,109,707 across 562 Biotechnology names. NUVB ranks #134 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in NUVB
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,894,231 | 1,373,947 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $5,514,001 | 615,402 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $3,359,972 | 908,101 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $924,181 | 473,939 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,534,177 | 871,692 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $4,922,843 | 1,850,693 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,065,099 | 465,109 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,166,782 | 399,583 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,542,639 | 423,802 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $575,791 | 381,319 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $128,112 | 95,606 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $171,577 | 95,321 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $183,187 | 110,354 | Shares | Defined | 2023-05-12 | |
| 2022-09-30 | $12,588 | 5,620 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $8,410 | 2,596 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $189 | 36 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,326 | 509 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $864 | 87 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $623 | 67 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $21,558 | 2,063 | Shares | Sole | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||